CD55 and prostate carcinoma: Recently, by tissue microarray analysis in prostate tumor epithelial cells, Loberg et al. demonstrated the overexpression of CD55 in clinical specimens from patients with advanced prostate cancer, compared to a normal non-malignant prostate [50].